Market access and its challenges have filled many column inches in recent years. Organisations like NICE have now been established for over 10 years and the NHS, although ever changing, has been set ...
Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS). The ...
HUNTINGTON BEACH, Calif. — Avoiding unplanned pregnancies in rheumatology patients can limit trauma and help steer clear of the labyrinth of U.S. abortion laws, according to a speaker at the 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback